中文 | EN | 日本語
Financial Reports Latest Updates Industry Maps Economic Calendar

Haoxi Health Technology Ltd (HAO) Annual Reports

Haoxi Health Technology Ltd is listed on Nasdaq, classified by the SEC under Services-Advertising Agencies (SIC 7311). This page indexes 2 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

  • Exchange: Nasdaq
  • Fiscal year end: 06/30
  • SEC CIK: 1954594 →

Website:Official site ↗

Financial Highlights

FY2026 (annual)
CurrentPrior yearYoY
Revenue $54.8M $537,646 +10097.9%
Operating income $-9.7M $-2.0M -383.2%
Net income $-9.5M $3.9M -346.0%
EPS (diluted) $-386.40 $1.32 -29372.7%

ADR filer (Form 20-F): annual data only.

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit
Annual · In mn (USD)
Revenue 54.8 mn Net income -9.54 mn
2022 2023 2024 2024 2025 2026

Periods follow the company’s fiscal year (Apple ends in September, Walmart in January), so they differ from calendar quarters.

Show table:Income statement
Item202220232024202420252026
Revenue16.2 28.2 1.19 —0.54 54.8
Gross profit0.65 2.06 2.75 —0.93 0.63
Operating income0.27 1.20 1.72 —-2.00 -9.66
Net income0.24 0.97 1.29 —3.88 -9.54
Balance sheet
Annual · In mn (USD)
Total assets 21.6 mn Total liabilities 3.71 mn
2022 2023 2024 2024 2025 2026

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table:Balance sheet
Item202220232024202420252026
Current assets—3.67 15.4 19.8 19.6 16.8
Total assets—4.46 15.5 22.1 21.6 21.6
Current liabilities—2.58 3.87 3.29 3.89 3.71
Total liabilities—2.90 4.23 3.32 4.22 3.71
Equity-1.47 1.57 11.3 18.7 17.4 17.9
Cash flow
Annual · In mn (USD)
Operating -2.57 mn Investing -4.50 mn Financing 9.33 mn
2022 2023 2024 2024 2025 2026

Positive = cash in, negative = cash out.

Show table:Cash flow statement
Item202220232024202420252026
Operating-0.68 -0.87 -0.75 —-3.36 -2.57
Investing-0.01 -0.05 -3.13 —-3.58 -4.50
Financing0.93 1.80 9.32 —8.90 9.33
Cash at period end0.29 1.20 6.66 9.10 8.62 10.9
Profitability
Annual · %
Gross margin 1.1% Operating margin -17.6% Net margin -17.4%
2022 2023 2024 2024 2025 2026

Gross, operating and net margin = the respective profit ÷ revenue.

Show table:Profitability
Item202220232024202420252026
Gross margin4.0%7.3%232.1%—172.6%1.1%
Operating margin1.7%4.2%144.9%—-372.0%-17.6%
Net margin1.5%3.4%109.0%—721.0%-17.4%
Returns & leverage
Annual · %
ROE -54.1% ROA -44.2% Debt ratio 17.2%
2022 2023 2024 2024 2025 2026

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table:Returns & leverage
Item202220232024202420252026
ROE—1923.7%20.1%—21.5%-54.1%
ROA—21.7%12.9%—17.8%-44.2%
Debt ratio—64.9%27.3%15.1%19.5%17.2%
EPS
Annual · US$
EPS US$-386.40
2022 2023 2024 2024 2025 2026
Show table:EPS
Item202220232024202420252026
EPS(US$)0.010.040.04—1.32-386.40

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

20-F: annual report of a foreign private issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Haoxi Health Technology Ltd (HAO) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 2 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.